GERALD M REID
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology KANSAS CITY, MO NPI 1013984731
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology MO Relypsa, Inc. All categories
General Payments — all program years on this page
$445.34
- Category: General Payments
- Program years: PY2018–2019
- Record count: 25
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $145.93 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $145.93 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Relypsa, Inc. | $39.41 | 2 |
| AKEBIA THERAPEUTICS INC | $35.00 | 2 |
| Shire North American Group Inc | $22.85 | 1 |
| Daiichi Sankyo Inc. | $22.56 | 1 |
| OPKO Pharmaceuticals, LLC | $13.09 | 1 |
| Acerta Pharma LLC | $13.02 | 1 |
By program year
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 637902947 | Shire North American Group Inc | $22.85 | 08/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 683909109 | Relypsa, Inc. | $17.24 | 03/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 683917269 | Relypsa, Inc. | $22.17 | 06/25/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 685282635 | AstraZeneca Pharmaceuticals LP | $13.02 | 05/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 695332835 | Daiichi Sankyo Inc. | $22.56 | 07/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 706553875 | AKEBIA THERAPEUTICS INC | $21.33 | 07/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 706553877 | AKEBIA THERAPEUTICS INC | $13.67 | 02/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 707775355 | OPKO Pharmaceuticals, LLC | $13.09 | 06/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.